Kane Biotech Inc (KNE : TSX-V)
Common Stock
$0.03
CAD
+0.00 (%)
Last updated: 2026-07-13
KNE
Kane Biotech Inc
WealthAwesomePerformance
1 Day
+0.00%
1 Week
-16.67%
1 Month
-16.67%
YTD
-37.50%
Key Statistics
Market Cap
$5.13M
52W High
$0.05
52W Low
$0.02
P/E Ratio
-
50 Day MA
$0.03
200 Day MA
$0.04
Beta
0.31
Dividend Yield
-
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 7/13/2026 | $0.03 | $0.03 | $0.03 | $0.03 | $0.03 | 198,000 |
| 7/9/2026 | $0.03 | $0.03 | $0.03 | $0.03 | $0.03 | 11,110 |
| 7/8/2026 | $0.03 | $0.03 | $0.03 | $0.03 | $0.03 | 4,000 |
| 7/6/2026 | $0.03 | $0.03 | $0.02 | $0.03 | $0.03 | 421,000 |
| 7/3/2026 | $0.03 | $0.03 | $0.03 | $0.03 | $0.03 | 504,000 |
| 7/2/2026 | $0.03 | $0.03 | $0.03 | $0.03 | $0.03 | 0 |
| 6/30/2026 | $0.03 | $0.03 | $0.03 | $0.03 | $0.03 | 6,800 |
| 6/29/2026 | $0.03 | $0.03 | $0.03 | $0.03 | $0.03 | 0 |
| 6/26/2026 | $0.03 | $0.03 | $0.03 | $0.03 | $0.03 | 11,000 |
| 6/25/2026 | $0.03 | $0.03 | $0.03 | $0.03 | $0.03 | 1,000 |
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on KNE's historical volatility
30-Day Vol
128.0%
Annualized
90-Day Vol
142.8%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.02
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.02 | C$0.02 – C$0.04 |
| 60 trading days | C$0.02 | C$0.01 – C$0.04 |
| 90 trading days | C$0.02 | C$0.01 – C$0.04 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Kane Biotech Inc
Kane Biotech Inc., a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops its products using coactiv+ technology, a biofilm destabilizing formula with continuous activity; and DispersinB technology, a naturally occurring enzyme that cleaves the bacterial surface polysaccharide poly-b-1, 6-N-acetylglucosamine (PNAG) for treating wounds and otic infections. Its wound care product portfolio includes antimicrobial wound gel, antimicrobial wound gel spray, and antimicrobial wound rinse under revyve name, as well as antimicrobial surgical hydrogel under coactiv+ name. In addition, the company offers scalp detoxifier product line under the Omni Bioceuticals brand. Further, it engages in developing coactiv+ Antimicrobial Surgical Hydrogel for use in surgical/acute wounds; revyve Antimicrobial Wound Rinse for use in acute and chronic wounds; DispersinB Hydrogel for use in surgical/acute wounds; and DispersinB Acne Cleanser for use in the treatment of mild to moderate acne vulgaris. Kane Biotech Inc. was incorporated in 2001 and is based in Winnipeg, Canada.
Financials
- Revenue (TTM)
- $58,574
- EBITDA
- $-2.09M
- Profit Margin
- 0.00%
- ROE (TTM)
- -596.80%
- EPS (Diluted)
- -0.01
- Book Value
- -0.01
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
Advertisement
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Common Questions About KNE
Articles Featuring KNE.V
Latest articles and analysis covering KNE.V
